Trials / Completed
CompletedNCT01718886
European Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss
Feasibility Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- Obalon Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the initial safety and preliminary effectiveness of the Obalon intragastric balloon system in European subjects with a BMI in the range of 27 - 35 kg/m\^2
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Obalon Gastric Balloon |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2012-10-31
- Last updated
- 2012-10-31
Locations
2 sites across 2 countries: Belgium, France
Source: ClinicalTrials.gov record NCT01718886. Inclusion in this directory is not an endorsement.